Van Tuyl Christopher

Chief Legal OfficerImmunovant, Inc. (IMVT) · full profile →Form 4 · filed Dec 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$291K
Net Open-Market Flow
-$291K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2025Sell(S)2K$27.38$63K150K
Dec 18, 2025Sell(S)9K$26.78$228K152K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001764013-25-000163) within minutes of acceptance. Every field above traces to the original document. Verify it directly: